These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31544248)

  • 21. Neonatal vaccine effectiveness and the role of adjuvants.
    Sakala IG; Eichinger KM; Petrovsky N
    Expert Rev Clin Immunol; 2019 Aug; 15(8):869-878. PubMed ID: 31293189
    [No Abstract]   [Full Text] [Related]  

  • 22. Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen.
    Donadei A; Gallorini S; Berti F; O'Hagan DT; Adamo R; Baudner BC
    Mol Pharm; 2015 May; 12(5):1662-72. PubMed ID: 25867449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory effect of glucan on specific and nonspecific immunity after vaccination in puppies.
    Haladová E; Mojžišová J; Smrčo P; Ondrejková A; Vojtek B; Prokeš M; Petrovová E
    Acta Vet Hung; 2011 Mar; 59(1):77-86. PubMed ID: 21354943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the immunomodulatory properties of glucan particles in human primary cells.
    Jesus S; Panão Costa J; Colaço M; Lebre F; Mateus D; Sebastião AI; Cruz MT; Alfaro-Moreno E; Borges O
    Int J Pharm; 2024 Apr; 655():123996. PubMed ID: 38490404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β-glucan microparticles targeted to epithelial APN as oral antigen delivery system.
    Baert K; de Geest BG; de Rycke R; da Fonseca Antunes AB; de Greve H; Cox E; Devriendt B
    J Control Release; 2015 Dec; 220(Pt A):149-159. PubMed ID: 26485047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
    Corthésy B; Bioley G
    Front Immunol; 2018; 9():431. PubMed ID: 29563912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of soluble β-glucan as an immune stimulant.
    Wu L; Zhao J; Zhang X; Liu S; Zhao C
    Int J Biol Macromol; 2021 May; 179():116-124. PubMed ID: 33667560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization.
    Wei J; Xue W; Yu X; Qiu X; Liu Z
    J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving vaccine delivery using novel adjuvant systems.
    Pichichero ME
    Hum Vaccin; 2008; 4(4):262-70. PubMed ID: 18398303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Glucan-A promising immunocyte-targeting drug delivery vehicle: Superiority, applications and future prospects.
    He L; Zhu Z; Qi C
    Carbohydr Polym; 2024 Sep; 339():122252. PubMed ID: 38823919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-->3)-linked bond and biased towards M2/Th2.
    Dong SF; Chen JM; Zhang W; Sun SH; Wang J; Gu JX; Boraschi D; Qu D
    Int Immunopharmacol; 2007 Jun; 7(6):725-33. PubMed ID: 17466906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microparticulate β-glucan vaccine conjugates phagocytized by dendritic cells activate both naïve CD4 and CD8 T cells in vitro.
    Berner VK; duPre SA; Redelman D; Hunter KW
    Cell Immunol; 2015; 298(1-2):104-14. PubMed ID: 26549577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
    Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
    J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
    Wang T; Wang N
    Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in vaccine delivery.
    Cordeiro AS; Alonso MJ
    Pharm Pat Anal; 2016; 5(1):49-73. PubMed ID: 26667309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives.
    Patil V; Hernandez-Franco JF; HogenEsch H; Renukaradhya GJ
    Front Immunol; 2022; 13():858321. PubMed ID: 36119085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined adjuvant-delivery system for new generation vaccine antigens: alliance has its own advantage.
    Kaurav M; Madan J; Sudheesh MS; Pandey RS
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S818-S831. PubMed ID: 30307332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-glucans as conductors of immune symphonies.
    Dalmo RA; Bøgwald J
    Fish Shellfish Immunol; 2008 Oct; 25(4):384-96. PubMed ID: 18606550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.